JP2014515258A5 - - Google Patents

Download PDF

Info

Publication number
JP2014515258A5
JP2014515258A5 JP2014510832A JP2014510832A JP2014515258A5 JP 2014515258 A5 JP2014515258 A5 JP 2014515258A5 JP 2014510832 A JP2014510832 A JP 2014510832A JP 2014510832 A JP2014510832 A JP 2014510832A JP 2014515258 A5 JP2014515258 A5 JP 2014515258A5
Authority
JP
Japan
Prior art keywords
cell population
multiple sclerosis
protein
cell
myelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014510832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014515258A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/059313 external-priority patent/WO2012156522A1/en
Publication of JP2014515258A publication Critical patent/JP2014515258A/ja
Publication of JP2014515258A5 publication Critical patent/JP2014515258A5/ja
Pending legal-status Critical Current

Links

JP2014510832A 2011-05-19 2012-05-18 免疫調節活性を有する細胞集団、その調製方法、及び、その使用 Pending JP2014515258A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11166808.3 2011-05-19
EP11166808 2011-05-19
PCT/EP2012/059313 WO2012156522A1 (en) 2011-05-19 2012-05-18 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018072015A Division JP6592551B2 (ja) 2011-05-19 2018-04-04 免疫調節活性を有する細胞集団、その調製方法、及び、その使用

Publications (2)

Publication Number Publication Date
JP2014515258A JP2014515258A (ja) 2014-06-30
JP2014515258A5 true JP2014515258A5 (https=) 2015-07-02

Family

ID=46149436

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510832A Pending JP2014515258A (ja) 2011-05-19 2012-05-18 免疫調節活性を有する細胞集団、その調製方法、及び、その使用
JP2018072015A Active JP6592551B2 (ja) 2011-05-19 2018-04-04 免疫調節活性を有する細胞集団、その調製方法、及び、その使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018072015A Active JP6592551B2 (ja) 2011-05-19 2018-04-04 免疫調節活性を有する細胞集団、その調製方法、及び、その使用

Country Status (6)

Country Link
US (1) US20140348808A1 (https=)
EP (1) EP2710122B1 (https=)
JP (2) JP2014515258A (https=)
KR (1) KR20140071277A (https=)
ES (1) ES2487465T1 (https=)
WO (1) WO2012156522A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011056972A2 (en) * 2009-11-04 2011-05-12 Case Western Reserve University Compositions and methods of treating a t cell mediated disorder
FR2976580B1 (fr) * 2011-06-14 2013-05-31 Coatex Sas Epaississants non ioniques associatifs contenant des alkyls cyclohexylols, formulations les contenant et leurs utilisations.
EP3551749B1 (en) 2016-12-07 2023-09-27 East Carolina University Compositions and methods for in vitro cultivation and/or expansion of regulatory t cells
CN112867496B (zh) 2018-03-27 2026-03-17 阿尔茨治疗方法公司 用于治疗神经退行性疾病的基于car-treg的疗法
CN109913415B (zh) * 2019-03-26 2020-05-22 广东先康达生物科技有限公司 Treg细胞的培养液及其培养方法与应用
EP4396216A1 (en) * 2021-09-03 2024-07-10 Sangamo Therapeutics, Inc. Mog-binding proteins and uses thereof
TW202417616A (zh) * 2022-09-02 2024-05-01 財團法人醫藥工業技術發展中心 包含間質幹細胞的組成物在緩解骨髓纖維化上的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147865A1 (en) * 2002-02-07 2003-08-07 Benoit Salomon Cell therapy using immunoregulatory T-cells
EP1715889A4 (en) * 2004-01-08 2008-03-05 Univ California LYMPHOCYTES T REGULATORS SUPPRESSING AUTOIMMUNITY
CA2617583A1 (en) * 2005-08-02 2007-02-08 Centenary Institute Of Cancer Medicine And Cell Biology Method for identifying regulatory t cells
EP3184630B1 (en) 2005-09-23 2019-07-17 TiGenix, S.A.U. Cell populations having immunoregulatory activity, method for isolation and uses
EP2050814A1 (en) * 2007-10-17 2009-04-22 Txcell Compositions for treating multiple sclerosis
US20100291117A1 (en) * 2009-05-18 2010-11-18 Tinghua Cao Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseases
GB0918615D0 (en) 2009-10-23 2009-12-09 Cellerix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof

Similar Documents

Publication Publication Date Title
JP7072808B2 (ja) 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法
Foo et al. Comparing the therapeutic potential of stem cells and their secretory products in regenerative medicine
JP2014515258A5 (https=)
CN110177558B (zh) 用于病毒特异性t细胞的活化和扩增的平台
JP6948072B2 (ja) Cd8陽性t細胞を誘導する方法
Forostyak et al. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications
Juno et al. Invariant NKT cells: regulation and function during viral infection
Wieder Fibroblasts as turned agents in cancer progression
Chen et al. The application of umbilical cord‐derived MSCs in cardiovascular diseases
Yang et al. Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage
IN2014MN01781A (https=)
JP2018512047A5 (https=)
JP2016501013A5 (https=)
JP2017536826A5 (https=)
EP3170895A1 (en) Production method for pluripotent stem cells having antigen-specific t cell receptor gene
ES2487465T1 (es) Poblaciones celulares que tienen actividad immunoreguladora, método para la preparación y usos
JP2015502135A5 (https=)
JP2013507945A5 (https=)
WO2015099134A1 (ja) 再構成されたt細胞レセプター遺伝子を有する多能性幹細胞由来のt前駆細胞を用いる免疫細胞療法
Chang et al. Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α
ITUB20159750A1 (it) Metodo per la promozione ed il miglioramento delle proprieta? del tessuto adiposo, tessuto e cellule ottenute tramite detto metodo
Chen et al. Viral‐Directed Augmentation of Kupffer Cell Cross‐Presentation Provokes Antitumor Immunity Against Liver Metastasis
WO2021157685A1 (ja) ヒトT細胞由来iPS細胞由来の細胞傷害性T細胞
Fath-Bayati et al. Tracking of intraperitoneally and direct intrahepatic administered mesenchymal stem cells expressing miR-146a-5p in mice hepatic tissue
EP4329783A1 (en) Compositions and methods related to megakaryocyte-derived extracellular vesicles for fanconi anemia